John Lazarchick to Rituximab
This is a "connection" page, showing publications John Lazarchick has written about Rituximab.
Connection Strength
0.088
-
Rituximab in the treatment of acquired factor VIII inhibitors. Thromb Haemost. 2006 Jul; 96(1):84-7.
Score: 0.066
-
Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis. Am J Hematol. 2010 Aug; 85(8):627-9.
Score: 0.022